Infective complications after prostate biopsy: Outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, A prospective multinational multicentre prostate biopsy study

European Urology

Volumn 63, Issue 3, 2013, Pages 521-527

  Wagenlehner, Florian M E ^a   Van Oostrum, Edgar ^b   Tenke, Peter ^c   Tandogdu, Zafer ^d   Çek, Mete ^e   Grabe, Magnus ^f   Wullt, Björn ^g   Pickard, Robert ^h   Naber, Kurt G ⁱ   Pilatz, Adrian ^a   Weidner, Wolfgang ^a   Bjerklund Johansen, Truls E ^j  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b EAU Department   (Netherlands)

^c Jahn Ferenc Del Pesti korhaz Budapest   (Hungary)

^d Taksim Teaching Hospital   (Turkey)

^e TRAKYA UNIVERSITY   (Turkey)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g Section of Microbiology Immunology and Glycobiology (MIG)   (Sweden)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j AARHUS UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

Antibiotic resistance; Infective complications; Prostate biopsy; Urinary tract infection

Indexed keywords

QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; FEVER; HOSPITALIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; RISK FACTOR; URINARY TRACT INFECTION; UROGENITAL TRACT INFECTION; UROLOGY;

EID: 84872967763     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.06.003     Document Type: Article

References (22)

1. F.K. Chun, J.I. Epstein, and V. Ficarra Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature Eur Urol 58 2010 851 864
2. K.K. Hodge, J.E. McNeal, M.K. Terris, and T.A. Stamey Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate J Urol 142 1989 71 74 discussion 74-5
3. A.M. Bootsma, M.P. Laguna Pes, S.E. Geerlings, and A. Goossens Antibiotic prophylaxis in urologic procedures: a systematic review Eur Urol 54 2008 1270 1286
4. Wolf JS J, Bennett CJ, Dmochowski RR, et al. Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel. Best practice policy statement on urologic surgery antimicrobial prophylaxis. American Urological Association Web site. www.auanet.org/content/clinical-practice-guidelines/ clinical-guidelines.cfm#2. Updated 2012.
5. Grabe M, Bjerklund-Johansen TE, Botto H, et al. Guidelines on urological infections. European Association of Urology Web site. www.uroweb.org/gls/pdf/17- Urological%20infections-LR%20II.pdf. Updated 2012.
6. S. Loeb, H.B. Carter, and S.I. Berndt Complications after prostate biopsy: data from SEER-Medicare J Urol 186 2011 1830 1834
7. R.K. Nam, R. Saskin, and Y. Lee Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy J Urol 183 2010 963 968
8. S. Loeb, S. van den Heuvel, and X. Zhu Infectious complications and hospital admissions after prostate biopsy in a European randomized trial Eur Urol 61 2012 1110 1114
9. T.E. Bjerklund Johansen, M. Çek, and K. Naber Prevalence of hospital-acquired urinary tract infections in urology departments Eur Urol 51 2007 1100 1112 (Pubitemid 46281413)
10. T.E. Johansen, M. Çek, and K.G. Naber Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies Int J Antimicrob Agents 28 Suppl 1 2006 S91 S107
11. S. Lindstedt, U. Lindstrom, and E. Ljunggren Single-dose antibiotic prophylaxis in core prostate biopsy: impact of timing and identification of risk factors Eur Urol 50 2006 832 837 (Pubitemid 44332680)
12. M. Grabe, H. Botto, and M. Çek Preoperative assessment of the patient and risk factors for infectious complications and tentative classification of surgical field contamination of urological procedures World J Urol 30 2012 39 50
13. F.M. Wagenlehner, W. Weidner, F. Sorgel, and K.G. Naber The role of antibiotics in chronic bacterial prostatitis Int J Antimicrob Agents 26 2005 1 7 (Pubitemid 40854108)
14. M.B. Roach, T.E. Figueroa, and D. McBride Ciprofloxacin versus gentamicin in prophylaxis against bacteremia in transrectal prostate needle biopsy Urology 38 1991 84 87
15. D. Steensels, K. Slabbaert, and L. De Wever Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy - should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 18 2010 575 581
16. D.A. Williamson, S.A. Roberts, and D.L. Paterson Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen Clin Infect Dis 54 2012 1406 1412
17. F. Wagenlehner, J. Stower-Hoffmann, and W. Schneider-Brachert Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology Int J Antimicrob Agents 15 2000 207 211 (Pubitemid 30645470)
18. A.I. Hidron, J.R. Edwards, and J. Patel NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 Infect Control Hosp Epidemiol 29 2008 996 1011
19. M.N. Al-Hasan, B.D. Lahr, J.E. Eckel-Passow, and L.M. Baddour Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007 J Antimicrob Chemother 64 2009 169 174
20. K.B. Laupland, D.B. Gregson, and D.L. Church Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region Clin Microbiol Infect 14 2008 1041 1047 (Pubitemid 352748845)
21. M.A. Liss, A. Chang, and R. Santos Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy J Urol 185 2011 1283 1288
22. M.E. Falagas, A.C. Kastoris, A.M. Kapaskelis, and D.E. Karageorgopoulos Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review Lancet Infect Dis 10 2010 43 50